Insider Sale Details

Nigel J. Murtagh, Chief Risk Officer of Charles Schwab Corp. (NASDAQ:SCHW), filed a Form 4 indicating that he disposed of a total of 26,675 shares of Schwab common stock in early August 2026 under a pre‑arranged Rule 10b5‑1 trading plan. On August 6, 2026 he sold 1,897 shares at prices ranging from $109.00 to $109.045 per share, and on August 10, 2026 he sold an additional 24,778 shares at the same price range. The combined proceeds from these transactions amounted to $2,907,791, representing an approximate sale value of $2.9 million. The transaction prices were close to the stock’s 52‑week high of $109.32, while the market price at the time of reporting was $107.99.

Option Exercise Prior to Sale

Before the sales, Murtagh exercised non‑qualified stock options granted under Schwab’s 2013 Stock Incentive Plan. He exercised options for the same 1,897 shares on August 6 and for 24,778 shares on August 10, each at an exercise price of $46.81 per share. The total intrinsic value of the exercised options was $1,248,656.

Post‑Sale Holdings

Following the sales and option exercises, Murtagh directly held 57,972.4846 shares of Charles Schwab Corp. common stock. In addition, he held an indirect beneficial ownership of 2,621 shares through the company’s Employee Stock Purchase Plan (ESPP).

Recent Earnings and Analyst Reactions

In the same period, Charles Schwab reported second‑quarter fiscal 2026 earnings that exceeded consensus expectations. Adjusted earnings per share were $1.62, a 42 % year‑over‑year increase, beating the $1.55 estimate from Citizens and surpassing the consensus by $0.07 (5 %). The earnings beat prompted several analysts to raise their price targets: UBS increased its target to $128 while maintaining a Buy rating; Wolfe Research lifted its target to $127 citing the strong quarter and improved guidance; Piper Sandler raised its target to $118 with a Neutral rating, noting a constructive retail trading environment and balance‑sheet growth; Compass Point initiated coverage with a Buy rating and a $135 target, emphasizing the benefits of agentic trading features; and Citizens reaffirmed its Market Outperform rating with a $120 target.